Drug
Tadalafil 10 MG
Tadalafil 10 MG is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
1
25%
Ph not_applicable
2
50%
Ph phase_4
1
25%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Not yet recruiting1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)
Trials by Status
not_yet_recruiting125%
recruiting125%
completed250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
NCT05051436
not_yet_recruitingphase_1
A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers
NCT04762082
completednot_applicable
Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
NCT03566914
completednot_applicable
Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction
NCT03834610
Clinical Trials (4)
Showing 4 of 4 trials
NCT05051436Phase 4
The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
NCT04762082Phase 1
A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers
NCT03566914Not Applicable
Tadalafil for Erectile Dysfunction in Patients With Cirrhosis
NCT03834610Not Applicable
Daily Oral L-arginine Plus Tadalafil in Diabetic Patients With Erectile Dysfunction
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4